Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 1Hepatitis C 1Hepatitis 1Carcinoma, Hepatocellular 1Bronchiolitis Obliterans Syndrome 1

Interventions

vedolizumab 1Sofosbuvir 1Ribavirin 1Photopheresis 1Mycophenolic Acid 1Methoxsalen 1Infliximab 1Azathioprine 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Hepatitis × Ribavirin × Clear all
NCT01559844 2016-07-27

Efficacy of Sofosbuvir With Ribavirin Administered Pre-Transplant in Preventing Hepatitis C Virus (HCV) Recurrence Post-Transplant

Gilead Sciences

Phase 2 Completed
61 enrolled 25 charts
Gastrointestinal

Bronchiolitis Obliterans Syndrome, Hepatitis, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡